Cited by

• Immune Checkpoint Inhibitor-Related Stress Cardiomyopathy: Differential Diagnosis and Key Role of Cardiac Imaging.

  Cobarro L, Valbuena-López S, Contreras C, Ugueto C, Ruiz-Gutiérrez I, Peña-López J, Ruiz-Giménez L, López-Fernández T. Cobarro L, et al. JACC Case Rep. 2023 Jun 21;16:101881. doi: 10.1016/j.jaccas.2023.101881. eCollection 2023 Jun 21. JACC Case Rep. 2023. PMID: 37396332 Free PMC article.
• Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases.

  Trontzas IP, Vathiotis IA, Kyriakoulis KG, Sofianidi A, Spyropoulou Z, Charpidou A, Kotteas EA, Syrigos KN; ImmunoTTS Collaborative Group. Trontzas IP, et al. Cancers (Basel). 2023 May 6;15(9):2637. doi: 10.3390/cancers15092637. Cancers (Basel). 2023. PMID: 37174104 Free PMC article. Review.
• Cardiovascular events after the initiation of immune checkpoint inhibitors.

  Suzuki Y, Kaneko H, Tamura Y, Okada A, Fujiu K, Michihata N, Takeda N, Jo T, Morita H, Node K, Yasunaga H, Komuro I. Suzuki Y, et al. Heliyon. 2023 May 18;9(5):e16373. doi: 10.1016/j.heliyon.2023.e16373. eCollection 2023 May. Heliyon. 2023. PMID: 37251893 Free PMC article.
• Molecular Mechanisms of Takotsubo Syndrome.

  Couch LS, Channon K, Thum T. Couch LS, et al. Int J Mol Sci. 2022 Oct 14;23(20):12262. doi: 10.3390/ijms232012262. Int J Mol Sci. 2022. PMID: 36293121 Free PMC article. Review.
• Mechanisms and Management of Immune Checkpoint Inhibitor-Related Cardiac Adverse Events.

  Kadowaki H, Akazawa H, Ishida J, Komuro I. Kadowaki H, et al. JMA J. 2021 Apr 15;4(2):91-98. doi: 10.31662/jmaj.2021-0001. Epub 2021 Apr 2. JMA J. 2021. PMID: 33997442 Free PMC article. Review.